can i take my tirzepatide at night Should Morning or Night? Timing Mounjaro Timing: Morning vs Night

High-fat dairy like full-fat cheese can trigger nausea or early fullness in the first 48 weeks of therapy, especially at higher doses

In routine care, approved medicines should follow the product label and a clinicians assessment

INTRODUCTION Tirzepatide is a synthetic peptide composed of 39 amino acids, which functions as a dual receptor agonist (RA) binding both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors and this unique mechanism of action resulted in the nickname twincretin. The structure of tirzepatide is based on that of the native GIP with the addition of a 20-carbon fatty diacid moiety, which increases its half-life to 5 days allowing for once-weekly administration.1 Studies using animal models of obesity and diabetes have shown that the co-administration of GIP and GLP-1 has synergistic effects in reducing body weight, food consumption, and fat mass.1 Tirzepatides dual agonist activity may result in these benefits in humans as well, as evidenced the significant reductions in glycated hemoglobin (HbA1c) levels and body weight in patients with type 2 diabetes mellitus (T2DM) observed in phase 3 clinical trials (such as, SURPASS

[1] [2] The synergistic effect of dual receptor activation appears to produce substantial weight loss and appetite reduction, though the complete mechanism of action is not fully characterized

The Health, Social Care and Sport Committee is consulting on a new Bill that would require treatments like fillers, microneedling, and Botox to be given by registered healthcare professionals in regulated settings

Lancet Diabetes Endocrinol 2(6):474480 Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, Li H, Li H, Jiang Y, Shuai Y, Zhang B, Zhang J, Gerzoff RB, Roglic G, Hu Y, Li G, Bennett PH (2011) Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study